Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 101

1.

Transportation innovation to aid Parkinson disease trial recruitment.

Frank S, Berk S, Hernandez L, Hogarth P, Shill HA, Siddiqi B, Simon DK.

Contemp Clin Trials Commun. 2019 Sep 10;16:100449. doi: 10.1016/j.conctc.2019.100449. eCollection 2019 Dec.

2.

Efficacy of Deep Brain Stimulation in a Patient with Genetically Confirmed Chorea-Acanthocytosis.

Richard A, Hsu J, Baum P, Alterman R, Simon DK.

Case Rep Neurol. 2019 Jun 26;11(2):199-204. doi: 10.1159/000500951. eCollection 2019 May-Aug.

3.

Altered muscle electrical tissue properties in a mouse model of premature aging.

Clark-Matott J, Nagy JA, Sanchez B, Taylor R, Riveros D, Abraham NA, Simon DK, Rutkove SB.

Muscle Nerve. 2019 Dec;60(6):801-810. doi: 10.1002/mus.26714. Epub 2019 Oct 30.

PMID:
31531861
4.

Genomewide association study of Parkinson's disease clinical biomarkers in 12 longitudinal patients' cohorts.

Iwaki H, Blauwendraat C, Leonard HL, Kim JJ, Liu G, Maple-Grødem J, Corvol JC, Pihlstrøm L, van Nimwegen M, Hutten SJ, Nguyen KH, Rick J, Eberly S, Faghri F, Auinger P, Scott KM, Wijeyekoon R, Van Deerlin VM, Hernandez DG, Gibbs JR; International Parkinson's Disease Genomics Consortium, Chitrala KN, Day-Williams AG, Brice A, Alves G, Noyce AJ, Tysnes OB, Evans JR, Breen DP, Estrada K, Wegel CE, Danjou F, Simon DK, Andreassen O, Ravina B, Toft M, Heutink P, Bloem BR, Weintraub D, Barker RA, Williams-Gray CH, van de Warrenburg BP, Van Hilten JJ, Scherzer CR, Singleton AB, Nalls MA.

Mov Disord. 2019 Sep 10. doi: 10.1002/mds.27845. [Epub ahead of print]

PMID:
31505070
5.

Genetic risk of Parkinson disease and progression:: An analysis of 13 longitudinal cohorts.

Iwaki H, Blauwendraat C, Leonard HL, Liu G, Maple-Grødem J, Corvol JC, Pihlstrøm L, van Nimwegen M, Hutten SJ, Nguyen KH, Rick J, Eberly S, Faghri F, Auinger P, Scott KM, Wijeyekoon R, Van Deerlin VM, Hernandez DG, Day-Williams AG, Brice A, Alves G, Noyce AJ, Tysnes OB, Evans JR, Breen DP, Estrada K, Wegel CE, Danjou F, Simon DK, Ravina B, Toft M, Heutink P, Bloem BR, Weintraub D, Barker RA, Williams-Gray CH, van de Warrenburg BP, Van Hilten JJ, Scherzer CR, Singleton AB, Nalls MA.

Neurol Genet. 2019 Jul 9;5(4):e348. doi: 10.1212/NXG.0000000000000348. eCollection 2019 Aug. Erratum in: Neurol Genet. 2019 Aug 15;5(4):e354.

6.

Revisiting protein aggregation as pathogenic in sporadic Parkinson and Alzheimer diseases.

Espay AJ, Vizcarra JA, Marsili L, Lang AE, Simon DK, Merola A, Josephs KA, Fasano A, Morgante F, Savica R, Greenamyre JT, Cambi F, Yamasaki TR, Tanner CM, Gan-Or Z, Litvan I, Mata IF, Zabetian CP, Brundin P, Fernandez HH, Standaert DG, Kauffman MA, Schwarzschild MA, Sardi SP, Sherer T, Perry G, Leverenz JB.

Neurology. 2019 Feb 12;92(7):329-337. doi: 10.1212/WNL.0000000000006926.

PMID:
30745444
7.

Targeting energy metabolism via the mitochondrial pyruvate carrier as a novel approach to attenuate neurodegeneration.

Quansah E, Peelaerts W, Langston JW, Simon DK, Colca J, Brundin P.

Mol Neurodegener. 2018 May 24;13(1):28. doi: 10.1186/s13024-018-0260-x. Review.

8.

Association of metabolic syndrome and change in Unified Parkinson's Disease Rating Scale scores.

Leehey M, Luo S, Sharma S, Wills AA, Bainbridge JL, Wong PS, Simon DK, Schneider J, Zhang Y, Pérez A, Dhall R, Christine CW, Singer C, Cambi F, Boyd JT.

Neurology. 2017 Oct 24;89(17):1789-1794. doi: 10.1212/WNL.0000000000004572. Epub 2017 Sep 29.

9.

Inverse probability weighted Cox regression for doubly truncated data.

Mandel M, de Uña-Álvarez J, Simon DK, Betensky RA.

Biometrics. 2018 Jun;74(2):481-487. doi: 10.1111/biom.12771. Epub 2017 Sep 8.

10.

Autonomic and electrocardiographic findings in Parkinson's disease.

Gibbons CH, Simon DK, Huang M, Tilley B, Aminoff MJ, Bainbridge JL, Brodsky M, Freeman R, Goudreau J, Hamill RW, Luo ST, Singer C, Videnovic A, Bodis-Wollner I, Wong PS; NINDS Exploratory Trials in Parkinson Disease (NET-PD) Investigators.

Auton Neurosci. 2017 Jul;205:93-98. doi: 10.1016/j.autneu.2017.04.002. Epub 2017 Apr 14.

11.

Factors associated with falling in early, treated Parkinson's disease: The NET-PD LS1 cohort.

Chou KL, Elm JJ, Wielinski CL, Simon DK, Aminoff MJ, Christine CW, Liang GS, Hauser RA, Sudarsky L, Umeh CC, Voss T, Juncos J, Fang JY, Boyd JT, Bodis-Wollner I, Mari Z, Morgan JC, Wills AM, Lee SL, Parashos SA; NINDS NET-PD Investigators.

J Neurol Sci. 2017 Jun 15;377:137-143. doi: 10.1016/j.jns.2017.04.011. Epub 2017 Apr 11.

12.

Mitochondrial DNA mutations in Parkinson's disease brain.

Simon DK, Matott JC, Espinosa J, Abraham NA.

Acta Neuropathol Commun. 2017 Apr 29;5(1):33. doi: 10.1186/s40478-017-0433-9. No abstract available.

13.

Caffeine, creatine, GRIN2A and Parkinson's disease progression.

Simon DK, Wu C, Tilley BC, Lohmann K, Klein C, Payami H, Wills AM, Aminoff MJ, Bainbridge J, Dewey R, Hauser RA, Schaake S, Schneider JS, Sharma S, Singer C, Tanner CM, Truong D, Wei P, Wong PS, Yang T.

J Neurol Sci. 2017 Apr 15;375:355-359. doi: 10.1016/j.jns.2017.02.032. Epub 2017 Feb 17.

14.

Biomarker-driven phenotyping in Parkinson's disease: A translational missing link in disease-modifying clinical trials.

Espay AJ, Schwarzschild MA, Tanner CM, Fernandez HH, Simon DK, Leverenz JB, Merola A, Chen-Plotkin A, Brundin P, Kauffman MA, Erro R, Kieburtz K, Woo D, Macklin EA, Standaert DG, Lang AE.

Mov Disord. 2017 Mar;32(3):319-324. doi: 10.1002/mds.26913. Epub 2017 Feb 24. Review.

15.

Multifocal repetitive TMS for motor and mood symptoms of Parkinson disease: A randomized trial.

Brys M, Fox MD, Agarwal S, Biagioni M, Dacpano G, Kumar P, Pirraglia E, Chen R, Wu A, Fernandez H, Wagle Shukla A, Lou JS, Gray Z, Simon DK, Di Rocco A, Pascual-Leone A.

Neurology. 2016 Nov 1;87(18):1907-1915. Epub 2016 Oct 5.

16.

Clinical Impact of 123I-Ioflupane SPECT (DaTscan) in a Movement Disorder Center.

Graebner AK, Tarsy D, Shih LC, Vanderhorst V, Kulkarni O, Kaplan S, Simon DK.

Neurodegener Dis. 2017;17(1):38-43. Epub 2016 Sep 10.

PMID:
27614874
17.

PLA2G6 mutations and Parkinsonism: Long-term follow-up of clinical features and neuropathology.

Klein C, Löchte T, Delamonte SM, Braenne I, Hicks AA, Zschiedrich-Jansen K, Simon DK, Friedman JH, Lohmann K.

Mov Disord. 2016 Dec;31(12):1927-1929. doi: 10.1002/mds.26814. Epub 2016 Oct 6. No abstract available.

PMID:
27709683
18.

CoQ10 in progressive supranuclear palsy: A randomized, placebo-controlled, double-blind trial.

Apetauerova D, Scala SA, Hamill RW, Simon DK, Pathak S, Ruthazer R, Standaert DG, Yacoubian TA.

Neurol Neuroimmunol Neuroinflamm. 2016 Aug 2;3(5):e266. doi: 10.1212/NXI.0000000000000266. eCollection 2016 Oct.

19.

Head injury at early ages is associated with risk of Parkinson's disease.

Taylor KM, Saint-Hilaire MH, Sudarsky L, Simon DK, Hersh B, Sparrow D, Hu H, Weisskopf MG.

Parkinsonism Relat Disord. 2016 Feb;23:57-61. doi: 10.1016/j.parkreldis.2015.12.005. Epub 2015 Dec 19.

20.

On the Control of the Fixed Charge Densities in Al2O3-Based Silicon Surface Passivation Schemes.

Simon DK, Jordan PM, Mikolajick T, Dirnstorfer I.

ACS Appl Mater Interfaces. 2015 Dec 30;7(51):28215-22. doi: 10.1021/acsami.5b06606. Epub 2015 Dec 16.

PMID:
26618751
21.

Complicated spontaneous intracranial hypotension treated with intrathecal saline infusion.

Stephen CD, Rojas R, Lioutas VA, Papavassiliou E, Simon DK.

Pract Neurol. 2016 Apr;16(2):146-9. doi: 10.1136/practneurol-2015-001231. Epub 2015 Oct 14. No abstract available.

PMID:
26467251
22.

Peripheral Biomarkers of Parkinson's Disease Progression and Pioglitazone Effects.

Simon DK, Simuni T, Elm J, Clark-Matott J, Graebner AK, Baker L, Dunlop SR, Emborg M, Kamp C, Morgan JC, Ross GW, Sharma S, Ravina B; NINDS NET-PD Investigators.

J Parkinsons Dis. 2015;5(4):731-6. doi: 10.3233/JPD-150666.

23.

Caffeine and Progression of Parkinson Disease: A Deleterious Interaction With Creatine.

Simon DK, Wu C, Tilley BC, Wills AM, Aminoff MJ, Bainbridge J, Hauser RA, Schneider JS, Sharma S, Singer C, Tanner CM, Truong D, Wong PS.

Clin Neuropharmacol. 2015 Sep-Oct;38(5):163-9. doi: 10.1097/WNF.0000000000000102.

24.

Metabolomic analysis of exercise effects in the POLG mitochondrial DNA mutator mouse brain.

Clark-Matott J, Saleem A, Dai Y, Shurubor Y, Ma X, Safdar A, Beal MF, Tarnopolsky M, Simon DK.

Neurobiol Aging. 2015 Nov;36(11):2972-2983. doi: 10.1016/j.neurobiolaging.2015.07.020. Epub 2015 Jul 21.

25.

Effect of creatine monohydrate on clinical progression in patients with Parkinson disease: a randomized clinical trial.

Writing Group for the NINDS Exploratory Trials in Parkinson Disease (NET-PD) Investigators, Kieburtz K, Tilley BC, Elm JJ, Babcock D, Hauser R, Ross GW, Augustine AH, Augustine EU, Aminoff MJ, Bodis-Wollner IG, Boyd J, Cambi F, Chou K, Christine CW, Cines M, Dahodwala N, Derwent L, Dewey RB Jr, Hawthorne K, Houghton DJ, Kamp C, Leehey M, Lew MF, Liang GS, Luo ST, Mari Z, Morgan JC, Parashos S, Pérez A, Petrovitch H, Rajan S, Reichwein S, Roth JT, Schneider JS, Shannon KM, Simon DK, Simuni T, Singer C, Sudarsky L, Tanner CM, Umeh CC, Williams K, Wills AM.

JAMA. 2015 Feb 10;313(6):584-93. doi: 10.1001/jama.2015.120.

26.

No sex differences in use of dopaminergic medication in early Parkinson disease in the US and Canada - baseline findings of a multicenter trial.

Umeh CC, Pérez A, Augustine EF, Dhall R, Dewey RB Jr, Mari Z, Simon DK, Wills AM, Christine CW, Schneider JS, Suchowersky O.

PLoS One. 2014 Dec 8;9(12):e112287. doi: 10.1371/journal.pone.0112287. eCollection 2014.

27.

Somatic mitochondrial DNA mutations do not increase neuronal vulnerability to MPTP in young POLG mutator mice.

Dai Y, Clark J, Zheng K, Kujoth GC, Prolla TA, Simon DK.

Neurotoxicol Teratol. 2014 Nov-Dec;46:62-7.

28.

A randomized clinical trial of high-dosage coenzyme Q10 in early Parkinson disease: no evidence of benefit.

Parkinson Study Group QE3 Investigators, Beal MF, Oakes D, Shoulson I, Henchcliffe C, Galpern WR, Haas R, Juncos JL, Nutt JG, Voss TS, Ravina B, Shults CM, Helles K, Snively V, Lew MF, Griebner B, Watts A, Gao S, Pourcher E, Bond L, Kompoliti K, Agarwal P, Sia C, Jog M, Cole L, Sultana M, Kurlan R, Richard I, Deeley C, Waters CH, Figueroa A, Arkun A, Brodsky M, Ondo WG, Hunter CB, Jimenez-Shahed J, Palao A, Miyasaki JM, So J, Tetrud J, Reys L, Smith K, Singer C, Blenke A, Russell DS, Cotto C, Friedman JH, Lannon M, Zhang L, Drasby E, Kumar R, Subramanian T, Ford DS, Grimes DA, Cote D, Conway J, Siderowf AD, Evatt ML, Sommerfeld B, Lieberman AN, Okun MS, Rodriguez RL, Merritt S, Swartz CL, Martin WR, King P, Stover N, Guthrie S, Watts RL, Ahmed A, Fernandez HH, Winters A, Mari Z, Dawson TM, Dunlop B, Feigin AS, Shannon B, Nirenberg MJ, Ogg M, Ellias SA, Thomas CA, Frei K, Bodis-Wollner I, Glazman S, Mayer T, Hauser RA, Pahwa R, Langhammer A, Ranawaya R, Derwent L, Sethi KD, Farrow B, Prakash R, Litvan I, Robinson A, Sahay A, Gartner M, Hinson VK, Markind S, Pelikan M, Perlmutter JS, Hartlein J, Molho E, Evans S, Adler CH, Duffy A, Lind M, Elmer L, Davis K, Spears J, Wilson S, Leehey MA, Hermanowicz N, Niswonger S, Shill HA, Obradov S, Rajput A, Cowper M, Lessig S, Song D, Fontaine D, Zadikoff C, Williams K, Blindauer KA, Bergholte J, Propsom CS, Stacy MA, Field J, Mihaila D, Chilton M, Uc EY, Sieren J, Simon DK, Kraics L, Silver A, Boyd JT, Hamill RW, Ingvoldstad C, Young J, Thomas K, Kostyk SK, Wojcieszek J, Pfeiffer RF, Panisset M, Beland M, Reich SG, Cines M, Zappala N, Rivest J, Zweig R, Lumina LP, Hilliard CL, Grill S, Kellermann M, Tuite P, Rolandelli S, Kang UJ, Young J, Rao J, Cook MM, Severt L, Boyar K.

JAMA Neurol. 2014 May;71(5):543-52. doi: 10.1001/jamaneurol.2014.131.

PMID:
24664227
29.

Computationally simple estimation and improved efficiency for special cases of double truncation.

Austin MD, Simon DK, Betensky RA.

Lifetime Data Anal. 2014 Jul;20(3):335-54. doi: 10.1007/s10985-013-9287-z. Epub 2013 Dec 18.

30.

Rapamycin drives selection against a pathogenic heteroplasmic mitochondrial DNA mutation.

Dai Y, Zheng K, Clark J, Swerdlow RH, Pulst SM, Sutton JP, Shinobu LA, Simon DK.

Hum Mol Genet. 2014 Feb 1;23(3):637-47. doi: 10.1093/hmg/ddt450. Epub 2013 Sep 18.

31.

Behavioral and metabolic characterization of heterozygous and homozygous POLG mutator mice.

Dai Y, Kiselak T, Clark J, Clore E, Zheng K, Cheng A, Kujoth GC, Prolla TA, Maratos-Flier E, Simon DK.

Mitochondrion. 2013 Jul;13(4):282-91. doi: 10.1016/j.mito.2013.03.006. Epub 2013 Mar 27.

32.

The inverse association of cancer and Alzheimer's: a bioenergetic mechanism.

Demetrius LA, Simon DK.

J R Soc Interface. 2013 Feb 20;10(82):20130006. doi: 10.1098/rsif.2013.0006. Print 2013 May 6.

33.

Pgc-1α overexpression downregulates Pitx3 and increases susceptibility to MPTP toxicity associated with decreased Bdnf.

Clark J, Silvaggi JM, Kiselak T, Zheng K, Clore EL, Dai Y, Bass CE, Simon DK.

PLoS One. 2012;7(11):e48925. doi: 10.1371/journal.pone.0048925. Epub 2012 Nov 7.

34.

An inverse-Warburg effect and the origin of Alzheimer's disease.

Demetrius LA, Simon DK.

Biogerontology. 2012 Dec;13(6):583-94. doi: 10.1007/s10522-012-9403-6. Epub 2012 Oct 20.

PMID:
23086530
35.

Genetic risk factors in Parkinson's disease: single gene effects and interactions of genotypes.

Göbel A, Macklin EA, Winkler S, Betensky RA, Klein C, Lohmann K, Simon DK.

J Neurol. 2012 Nov;259(11):2503-5. doi: 10.1007/s00415-012-6623-2. Epub 2012 Aug 10. No abstract available.

36.

Frequency of the D620N mutation in VPS35 in Parkinson disease.

Kumar KR, Weissbach A, Heldmann M, Kasten M, Tunc S, Sue CM, Svetel M, Kostić VS, Segura-Aguilar J, Ramirez A, Simon DK, Vieregge P, Münte TF, Hagenah J, Klein C, Lohmann K.

Arch Neurol. 2012 Oct;69(10):1360-4.

PMID:
22801713
37.

Somatic mitochondrial DNA mutations in early Parkinson and incidental Lewy body disease.

Lin MT, Cantuti-Castelvetri I, Zheng K, Jackson KE, Tan YB, Arzberger T, Lees AJ, Betensky RA, Beal MF, Simon DK.

Ann Neurol. 2012 Jun;71(6):850-4. doi: 10.1002/ana.23568.

38.

Meta-analysis of Parkinson's disease: identification of a novel locus, RIT2.

Pankratz N, Beecham GW, DeStefano AL, Dawson TM, Doheny KF, Factor SA, Hamza TH, Hung AY, Hyman BT, Ivinson AJ, Krainc D, Latourelle JC, Clark LN, Marder K, Martin ER, Mayeux R, Ross OA, Scherzer CR, Simon DK, Tanner C, Vance JM, Wszolek ZK, Zabetian CP, Myers RH, Payami H, Scott WK, Foroud T; PD GWAS Consortium.

Ann Neurol. 2012 Mar;71(3):370-84. doi: 10.1002/ana.22687.

39.

Singing in groups for Parkinson's disease (SING-PD): a pilot study of group singing therapy for PD-related voice/speech disorders.

Shih LC, Piel J, Warren A, Kraics L, Silver A, Vanderhorst V, Simon DK, Tarsy D.

Parkinsonism Relat Disord. 2012 Jun;18(5):548-52. doi: 10.1016/j.parkreldis.2012.02.009. Epub 2012 Mar 19.

PMID:
22436653
40.

Clinical vignettes in Parkinson's disease: a collection of unusual medication-induced hallucinations, delusions, and compulsive behaviours.

Friedman JH, Agarwal P, Alcalay R, Black KJ, Chou KL, Cote L, Dayalu P, Frank S, Hartlein J, Hauser RA, Lang AE, Marsh L, Marshall F, Moskowitz C, Ravina B, Riley D, Sanchez-Ramos J, Simon DK, Simuni T, Sutton J, Tuite P, Weintraub D, Zesiewicz T.

Int J Neurosci. 2011 Aug;121(8):472-6. doi: 10.3109/00207454.2011.578779. Epub 2011 Jun 10.

PMID:
21663381
41.

Do somatic mitochondrial DNA mutations contribute to Parkinson's disease?

Clark J, Dai Y, Simon DK.

Parkinsons Dis. 2011;2011:659694. doi: 10.4061/2011/659694. Epub 2011 Apr 27.

42.

Association of PGC-1alpha polymorphisms with age of onset and risk of Parkinson's disease.

Clark J, Reddy S, Zheng K, Betensky RA, Simon DK.

BMC Med Genet. 2011 May 19;12:69. doi: 10.1186/1471-2350-12-69.

43.

Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6.

Xiao J, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS.

Hum Genet. 2010 Apr;127(4):470. No abstract available.

PMID:
21488298
44.

Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6.

Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS.

Hum Genet. 2010 Apr;127(4):470. No abstract available.

PMID:
21488297
45.

Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6.

Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS.

Hum Genet. 2010 Apr;127(4):469-70. No abstract available.

PMID:
21488296
46.

Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6.

Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS.

Hum Genet. 2010 Apr;127(4):469. No abstract available.

PMID:
21488277
47.

Novel human pathological mutations. Gene symbol: THAP1. Disease: dystonia 6.

Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello R, Blitzer A, Batish SD, Wszolek ZK, Uitti RJ, Van Gerpen JA, Hedera P, Simon DK, Tarsy D, Truong DD, Frei KP, Pfeiffer RF, Gong S, LeDoux MS.

Hum Genet. 2010 Apr;127(4):470. No abstract available.

PMID:
21488252
48.

The c.-237_236GA>TT THAP1 sequence variant does not increase risk for primary dystonia.

Xiao J, Zhao Y, Bastian RW, Perlmutter JS, Racette BA, Tabbal SD, Karimi M, Paniello RC, Wszolek ZK, Uitti RJ, Van Gerpen JA, Simon DK, Tarsy D, Hedera P, Truong DD, Frei KP, Blitzer A, Rudzińska M, Pfeiffer RF, Le C, LeDoux MS.

Mov Disord. 2011 Feb 15;26(3):549-52. doi: 10.1002/mds.23551. Epub 2011 Mar 2. Erratum in: Mov Disord. 2012 Mar;27(3):465.

49.

Mitochondrial DNA haplogroups and mutations in children with acquired central demyelination.

Venkateswaran S, Zheng K, Sacchetti M, Gagne D, Arnold DL, Sadovnick AD, Scherer SW, Banwell B, Bar-Or A, Simon DK; Canadian Pediatric Demyelinating Disease Network.

Neurology. 2011 Mar 1;76(9):774-80. doi: 10.1212/WNL.0b013e31820ee1bb. Epub 2011 Feb 2.

50.

Mitochondria and Parkinson's disease.

Simon DK, Chu CT, Swerdlow RH.

Parkinsons Dis. 2011;2011:261791. doi: 10.4061/2011/261791. Epub 2012 Aug 29. No abstract available.

Supplemental Content

Loading ...
Support Center